The science is working. The investors are in. The path to market is real. And somewhere between the board meeting and the regulatory strategy conversation, it became clear: you need a lawyer. Not a firm you call when something breaks. A trusted legal advisor who understands your business, knows this industry from the inside, and can help you build the right foundation before you need it.
This isn’t a retainer for occasional questions. It’s executive-level legal leadership embedded in your business. Meredith leads the engagement, with support from her team as needed. Part of your leadership team, understands your pipeline, and gives you the kind of ongoing strategic guidance that anticipates issues before they become urgent.
Fractional GC engagements typically include:
And the steady, senior presence that means your leadership team always has someone in their corner who understands the full picture, including knowing when to bring in outside counsel or subject matter experts, and how to manage them effectively when we do.
This engagement is designed for pre-commercial and early commercial pharmaceutical, biopharma, biotech, and medical device companies that:
If you’re not sure whether you need this, that uncertainty is usually the answer.
Fractional GC engagements are structured as a monthly retainer, scoped to your business and adjusted as it evolves. Engagements typically begin with a scoping conversation to align on priorities, followed by an initial 90-day period to establish rhythm and integrate with your team. From there, scope and cadence are reviewed regularly to make sure the engagement keeps pace with the business.
Ready to talk about what this could look like for your company?